Lv61
2580 积分 2024-03-14 加入
Combination locoregional and systemic therapies in hepatocellular carcinoma
1小时前
已完结
Azobenzene-Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates
9天前
已完结
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
16天前
已完结
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukemia (ALFA-0701): a randomised, open-label, phase 3 study
21天前
已完结
Antibody–drug conjugates come of age in oncology
22天前
已完结
Exploring the next generation of antibody–drug conjugates
24天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
29天前
已关闭
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study
29天前
已关闭
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population
29天前
已完结
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
29天前
已完结
皖公网安备34019202002308
